A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection

[Image: see text] As the Ebola outbreak in West Africa continues and cases appear in the United States and other countries, the need for long-lasting vaccines to preserve global health is imminent. Here, we evaluate the long-term efficacy of a respiratory and sublingual (SL) adenovirus-based vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin Huk, Jonsson-Schmunk, Kristina, Qiu, Xiangguo, Shedlock, Devon J., Strong, Jim, Xu, Jason X., Michie, Kelly L., Audet, Jonathan, Fernando, Lisa, Myers, Mark J., Weiner, David, Bajrovic, Irnela, Tran, Lilian Q., Wong, Gary, Bello, Alexander, Kobinger, Gary P., Schafer, Stephen C., Croyle, Maria A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525323/
https://www.ncbi.nlm.nih.gov/pubmed/25363619
http://dx.doi.org/10.1021/mp500646d

Ejemplares similares

Ejemplares similares